Methadone Hydrochloride Concentrate
FDA Label NDC 66689-694

54 label sections · Submitted to the FDA by Vistapharm, Llc · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Vistapharm, Llc for the product Methadone Hydrochloride (NDC 66689-694). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding warning: life-threatening respiratory depression, life-threatening qt prolongation, accidental ingestion, abuse potential, interactions with drugs affecting cytochrome p450 isoenzymes and treatment for opioid addiction, 1 indications and usage, 2.1     conditions for distribution and use of methadone products for the treatment of opioid addiction, 2.2     important dosage and administration information, 2.3     patient access to an opioid overdose reversal agent for the emergency treatment of opioid overdose, 2.4     induction/initial dosing for detoxification and maintenance treatment of opioid addiction, 2.5     titration and maintenance treatment of opioid dependence, 2.6     medically supervised withdrawal after a period of maintenance treatment for opioid addiction, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

* Please review the disclaimer below.